
Thailand


February 2022: Dolutegravir as First- or Second-line Treatment for HIV-1 Infection in Children
Article and Study Summary: Dolutegravir as First- or Second-line Treatment for HIV-1 Infection in Children Published in: New England Journal of Medicine 2021,385(27):2531-2543. https://www.nejm.org/doi/full/10.1056/NEJMoa2108793 Authors: Turkova A, White E, Mujuru HA,...
May 2021: Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
Article: Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis Published in: N Engl J Med. 2021;384(18):1705-1718. https://www.nejm.org/doi/full/10.1056/NEJMoa2033400 Authors: Dorman SE, Nahid P, Kurbatova EV, et al. Summary: The Tuberculosis...
Human Immunodeficiency Virus Infection in Adolescents and Mode of Transmission in Southern Africa: A Multinational Analysis of Population-Based Survey Data
Andrea Low, Chloe Teasdale, Kristin Brown, Danielle T Barradas, Owen Mugurungi, Karam Sachathep, Harriet Nuwagaba-Biribonwoha, Sehin Birhanu, Andrew Banda, Koen Frederix, Danielle Payne, Elizabeth Radin, Lubbe Wiesner, Choice Ginindza, Neena Philip, Godfrey Musuka,...